By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company PaxMedica, Inc. Common Stock

PaxMedica, Inc. Common Stock (PXMD)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$25.13K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.16
52 Week Range

PXMD Stock Price Chart

Explore PaxMedica, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze PXMD price movements and trends.

PXMD Company Profile

Discover essential business fundamentals and corporate details for PaxMedica, Inc. Common Stock (PXMD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

26 Aug 2022

Employees

6.00

CEO

Howard J. Weisman

Description

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

PXMD Financial Timeline

Browse a chronological timeline of PaxMedica, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 20 Sept 2024

EPS came in at -$0.39 .

Earnings released on 13 May 2024

EPS came in at -$0.50 falling short of the estimated -$0.43 by -16.28%.

Earnings released on 3 Apr 2024

EPS came in at -$1.45 falling short of the estimated -$0.88 by -64.77%.

Earnings released on 15 Nov 2023

EPS came in at -$5.20 .

Stock split effective on 31 Oct 2023

Shares were split 1 : 17 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 9 Aug 2023

EPS came in at -$4.08 .

Earnings released on 15 May 2023

EPS came in at -$5.10 .

Earnings released on 29 Mar 2023

EPS came in at -$0.59 .

Earnings released on 15 Nov 2022

EPS came in at -$14.80 .

Earnings released on 30 Sept 2022

EPS came in at $0.00 .

Earnings released on 31 Mar 2022

EPS came in at $0.19 .

Earnings released on 31 Dec 2021

EPS came in at $0.62 .

Earnings released on 30 Sept 2021

EPS came in at -$0.31 .

Earnings released on 30 Jun 2021

EPS came in at -$0.61 .

Earnings released on 31 Mar 2021

EPS came in at -$0.72 .

Earnings released on 31 Dec 2020

EPS came in at -$0.44 .

Earnings released on 30 Sept 2020

EPS came in at -$0.22 .

PXMD Stock Performance

Access detailed PXMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run